SPG21 Antikörper (AA 211-307)
-
- Target Alle SPG21 Antikörper anzeigen
- SPG21 (Spastic Paraplegia 21 (SPG21))
-
Bindungsspezifität
- AA 211-307
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser SPG21 Antikörper ist unkonjugiert
-
Applikation
- ELISA
- Kreuzreaktivität
- Human
- Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
- Produktmerkmale
- SPG21 (Maspardin, Acid Cluster Protein 33, Spastic Paraplegia 21 Autosomal Recessive Mast Syndrome Protein, Spastic Paraplegia 21 Protein, ACP33, BM-019, GL010)
- Aufreinigung
- Purified by Protein A affinity chromatography.
- Immunogen
- Partial recombinant corresponding to aa211-307 from human SPG21 (NP_057714) with GST tag. MW of the GST tag alone is 26kD.
- Klon
- 2B11
- Isotyp
- IgG2a kappa
- Top Product
- Discover our top product SPG21 Primärantikörper
-
-
- Applikationshinweise
- Optimal working conditions should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Supplied as a liquid in PBS, pH 7.2.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- -20°C
-
- Target
- SPG21 (Spastic Paraplegia 21 (SPG21))
- Andere Bezeichnung
- SPG21 (SPG21 Produkte)
- Synonyme
- ACP33 antikoerper, GL010 antikoerper, MAST antikoerper, BM-019 antikoerper, C78576 antikoerper, D9Wsu18e antikoerper, Maspardin antikoerper, wu:fd07h02 antikoerper, zgc:73091 antikoerper, SPG21, maspardin antikoerper, spastic paraplegia 21 (autosomal recessive, Mast syndrome) antikoerper, SPG21, maspardin S homeolog antikoerper, SPG21 antikoerper, Spg21 antikoerper, spg21.S antikoerper, spg21 antikoerper
- NCBI Accession
- NM_016630, NP_057714
-